AbbVie Inc., US00287Y1091

AbbVie stock heads into the open after a flat close

Published on 09/25/2026 at 06:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, AbbVie stock finished at USD 264.93, with a USD 263.25 to USD 267.32 range and a Nasdaq Composite gain of 0.01 percent.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie stock closed at USD 264.93 on the New York Stock Exchange on September 24, 2026, unchanged from the prior session. The Nasdaq Composite rose 0.01 percent to 26,939.37, leaving AbbVie flat against a slightly positive benchmark.

September 24, 2026 in numbers

AbbVie Inc. (ISIN US00287Y1091) traded between USD 263.25 and USD 267.32 on the New York Stock Exchange, while the session volume reached 260,869 shares. The close stood 1.64 percent below the 52-week high of USD 269.34 and 38.61 percent above the 52-week low of USD 191.17, both reported with September 24, 2026 market data.

finanzen.ch reported that AbbVie traded near the prior-session level late in the New York session, after reaching its 52-week high one session earlier.

Today and the next sessions

The next quarterly results are scheduled for October 23, 2026, according to finanzen.ch. That date falls outside the next five trading sessions, so the immediate calendar focus remains the US market session beginning today.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70181311 | bgmi